Trade Summary

4 days ago, Bergstrom Donald A, serving as President, R&D at Relay Therapeutics, Inc. (RLAY), sold 93,456 shares at $16.94 per share, for a total transaction value of $1,583,144.64. Following this transaction, Bergstrom Donald A now holds 418,557 shares of RLAY.

This sale represents a 18.25% decrease in Bergstrom Donald A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:09 PM ET, 2 days after the trade was made.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.